A single centric, open labeled, observational study of selected ayurvedic therapies in the management of diabetic retinopathy, grade-1.

Dept of AYUSH Ministry of HealthGovt of IndiaNew Delhi0 个研究点目标入组 50 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients of either sex aged between 30 to 80 years.
•Patients presenting with signs and symptoms of Diabetic Retinopathy grade 1(US) with micro aneurysm and hemorrhage in one or two quadrants as seen in the Fundus Image.
•Willing and able to participate in the study for 12 months.

•Severe cases of Diabetic Retinopathy with complications like internal haemorrhage, hard exudates, retinal detachment etc.
•Patients with concurrent serious Hepatic Dysfunction (defined as AST and/or ALT > 3 times of the upper normal limit) or Renal Dysfunction (defined as S. creatinine > 1.2mg/dl), uncontrolled Pulmonary Dysfunction (asthmatic and COPD patients) or other concurrent severe disease.
•Patient with poorly controlled Diabetes Mellitus (HbA1c > 10%)
•Women who are pregnant or lactating.
•Patient on steroids, oral contraceptive pills or estrogen replacement therapy.
•Smokers/Alcoholics and/or drug abusers.
•Patient with poorly controlled Hypertension ( >160/100 mm of Hg).
•Patients with evidence of malignancy.
•Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro- Endocrinal disorders, etc.).
•Any other condition which the P.I. thinks may jeopardize the study.

发起方

Dept of AYUSH Ministry of HealthGovt of IndiaNew Delhi